Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This piece walks through why forks occur in blockchains, from protocol changes to governance decisions, with real-world examples to illustrate the process.
18,016 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
AI growth stocks may ride the wave of innovation, but a stubborn helium shortage could cap upside. Even if Iran ends,...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
A major investment fund disclosed a $13.93 million exit from a booming AI investment in Q1 2026. Here’s what this mov...
Bitcoin has seen wild swings, but a bold forecast remains on the table. This article breaks down why some investors b...
Planners often treat retirement income as a moving target. This guide explains how to build a durable paycheck from i...
The SpaceX IPO could reshape tech investing, with a potential $1.6 trillion valuation on the table. This guide breaks...
Bitcoin has traded in volatile swings, prompting the question will bitcoin fall below $50,000. This guide breaks down...
Investors are eyeing the microreactor trend and Nano Nuclear Energy. This guide breaks down the potential, risks, and...
NFL loyalty runs deep, but the families behind the game often carry unseen costs. This article digs into Mindy Armste...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
Intuit has fallen hard this year, but a big drawdown can create a patient entry point. This guide breaks down the bus...